Clinical Practice Guideline: Focused Update
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

https://doi.org/10.1016/j.jacc.2017.04.025Get rights and content
Under an Elsevier user license
open archive

Key Words

ACC/AHA Clinical Practice Guidelines
angioedema
angiotensin-converting enzyme inhibitors
angiotensin receptor blockers
angiotensin receptor-neprilysin inhibitor
beta blockers
ferric carboxymaltose
focused update
heart failure
hypertension
iron deficiency
ivabradine
natriuretic peptides
natriuretic peptide biomarker
sleep apnea

Cited by (0)

Developed in Collaboration with the American Academy of Family Physicians, American College of Chest Physicians, and International Society for Heart and Lung Transplantation

This document was approved by the American College of Cardiology Clinical Policy Approval Committee, the American Heart Association Science Advisory and Coordinating Committee, the American Heart Association Executive Committee, and the Heart Failure Society of America Executive Committee in April 2017.

The American College of Cardiology requests that this document be cited as follows: Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70:776–803.

This article has been copublished in Circulation and the Journal of Cardiac Failure.

Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (professional.heart.org), and the Heart Failure Society of America (www.hfsa.org). For copies of this document, please contact the Elsevier Reprint Department via fax (212-633-3820) or e-mail ([email protected]).

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology. Requests may be completed online via the Elsevier site (https://www.elsevier.com/about/our-business/policies/copyright/permissions).

Writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information.

ACC/AHA Task Force on Clinical Practice Guidelines Liaison.

ACC/AHA Representative.

§

ACP Representative.

ISHLT Representative.

HFSA Representative.

#

CHEST Representative.

∗∗

ACC/AHA Task Force on Performance Measures Representative.

††

AAFP Representative.